🇺🇸 FDA
Patent

US 9919051

Liquid formulation comprising GM-CSF neutralizing compound

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 9919051 (Liquid formulation comprising GM-CSF neutralizing compound) held by TAKEDA GMBH expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TAKEDA GMBH
Grant date
Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/505, A61K39/395, A61K39/3955, A61K39/39591